Singapore, March 24 -- PharmaMar, a Spanish biopharmaceutical company with 40 years of experience, has announced that its treatment Zepzelca(R) (lurbinectedin), in combination with atezolizumab (Tecen... Read More
Singapore, March 24 -- CHA Biotech and Novartis Korea have signed a strategic Memorandum of Understanding (MoU) to establish a collaborative framework for bio open innovation based on the Cell Gene Bi... Read More